Lyra Therapeutics, Inc. — Department of Health and Human Services SBIR Phase II: ODHLBI

Lyra Therapeutics, Inc. — SBIR Phase II award from Department of Health and Human Services.

Amount
$512,507
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
ODHLBI
NAICS
Place of performance
MA
Period

Description

Not Available